Cargando…

The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis

BACKGROUND: To investigate the effect of baseline clinical characteristics and glucocorticoid treatment on temporal artery biopsy (TAB) findings in patients with giant cell arteritis (GCA). METHODS: Individuals who developed GCA after inclusion in two population-based health surveys were identified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakobsson, Karin, Jacobsson, Lennart, Mohammad, Aladdin J., Nilsson, Jan-Åke, Warrington, Kenneth, Matteson, Eric L., Turesson, Carl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997683/ https://www.ncbi.nlm.nih.gov/pubmed/27558589 http://dx.doi.org/10.1186/s12891-016-1225-2

Ejemplares similares

Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis
por: Wadström, Karin, et al.
Publicado: (2020)

Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis: a prospective study
por: Wadström, Karin, et al.
Publicado: (2022)

Comment on: Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: reply
por: Wadström, Karin, et al.
Publicado: (2021)

Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden—an update on incidence and first prevalence estimate
por: Stamatis, Pavlos, et al.
Publicado: (2021)

Pathogenesis of giant cell arteritis with focus on cellular populations
por: Stamatis, Pavlos, et al.
Publicado: (2022)

Comment on: Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden—an update on incidence and first prevalence estimate: reply
por: Stamatis, Pavlos, et al.
Publicado: (2021)

Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes
por: Wiberg, Frans, et al.
Publicado: (2021)

Cardiovascular co-morbidity in rheumatic diseases
por: Turesson, Carl, et al.
Publicado: (2008)

Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?
por: Gisslander, Karl, et al.
Publicado: (2023)

Clinical and Radiographic Features of Giant Cell Arteritis With Intracranial Involvement
por: Sanchez‐Alvarez, Catalina, et al.
Publicado: (2020)

Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study
por: Lo Gullo, Alberto, et al.
Publicado: (2016)

Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets
por: Koster, Matthew J., et al.
Publicado: (2017)

Looking ahead: giant-cell arteritis in 10 years time
por: Bond, Milena, et al.
Publicado: (2022)

Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis: a population-based case–control study
por: Turkiewicz, Aleksandra, et al.
Publicado: (2020)

Changes and sex differences in patient reported outcomes in rheumatoid factor positive RA–results from a community based study
por: Hekmat, Korosh, et al.
Publicado: (2014)

Early menopause and severity of rheumatoid arthritis in women older than 45 years
por: Pikwer, Mitra, et al.
Publicado: (2012)

High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study
por: Turesson, Carl, et al.
Publicado: (2015)

Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis
por: Rydell, Emil, et al.
Publicado: (2018)

Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides—Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort
por: Palmowski, Andriko, et al.
Publicado: (2022)

Diagnosis of giant cell arteritis by temporal artery biopsy is associated with biopsy length
por: Ruediger, Carlee, et al.
Publicado: (2022)

Clinical and Pathological Evolution of Giant Cell Arteritis: A Prospective Study of Follow-Up Temporal Artery Biopsies in 40 Treated Patients
por: Maleszewski, Joseph J., et al.
Publicado: (2017)

Clinical Images: Tongue ulceration in giant cell arteritis associated with asymptomatic retinal ischemia
por: Guarda, Max, et al.
Publicado: (2023)

19. Unusual findings in giant cell arteritis
por: Zacharias, Hannah, et al.
Publicado: (2018)

Temporal artery biopsy for giant cell arteritis: retrospective audit
por: Saedon, Habiba, et al.
Publicado: (2012)

Stratified glucocorticoid monotherapy is safe and effective for most cases of giant cell arteritis
por: Karabayas, Maira, et al.
Publicado: (2020)

Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
por: Emamifar, Amir, et al.
Publicado: (2021)

Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis
por: Tomelleri, Alessandro, et al.
Publicado: (2022)

Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort
por: Esen, Idil, et al.
Publicado: (2023)

Do solar cycles influence giant cell arteritis and rheumatoid arthritis incidence?
por: Wing, Simon, et al.
Publicado: (2015)

Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis - results from a well defined population in south Sweden
por: Hekmat, Korosh, et al.
Publicado: (2011)

Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors—data from a large national quality register
por: Cagnotto, Giovanni, et al.
Publicado: (2020)

Genetic Predispositions of Glucocorticoid Resistance and Therapeutic Outcomes in Polymyalgia Rheumatica and Giant Cell Arteritis
por: Smutny, Tomas, et al.
Publicado: (2019)

Healthcare Costs of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis
por: Best, Jennie H, et al.
Publicado: (2019)

Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering
por: Venerito, Vincenzo, et al.
Publicado: (2022)

39. Atypical presentation of giant cell arteritis confirmed on brain biopsy
por: Ahmad, Nadia, et al.
Publicado: (2019)

Changes in bone mineral density over 10 years in patients with early rheumatoid arthritis
por: Theander, Lisa, et al.
Publicado: (2020)

Predictors of radiographic erosion and joint space narrowing progression in patients with early rheumatoid arthritis: a cohort study
por: Rydell, Emil, et al.
Publicado: (2021)

Clinical Features and Outcomes of Japanese Patients with Giant Cell Arteritis: A Comparison with Takayasu Arteritis
por: Yoshida, Shuhei, et al.
Publicado: (2023)

Intraorbital findings in giant cell arteritis on black blood MRI
por: Guggenberger, Konstanze V., et al.
Publicado: (2022)

Glucocorticoid Effects on Tissue Residing Immune Cells in Giant Cell Arteritis: Importance of GM-CSF
por: Wagner, Annette D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7iveiam76thvm07ovsltm07rrt